The Psoriasis Treatment Market: A Response to a Global Health Crisis
The Psoriasis Treatment Market is a critical sector in addressing a global health crisis related to chronic skin conditions. The market is on a robust growth trajectory, expected to reach a valuation of $57 billion by 2032 from $27 billion in 2024, with a projected CAGR of over 10%. This growth is a direct result of the urgent need for new solutions as the burden of psoriasis increases worldwide. This has led to a boom in research and development for innovative products, including both biologic and topical treatments.
In terms of market segments, the biologic drug segment is experiencing rapid growth, signaling a shift in how chronic conditions are treated. The topical treatments segment still holds a significant share, but its dynamics are changing. Geographically, while North America continues to lead the market, the Asia-Pacific region is emerging as a global leader in growth, driven by increasing healthcare expenditure and a large, dense population. For a deeper understanding of this market, you can view the full report at Market Research Future.